Quizartinib, a selective FLT3 inhibitor, maintains anti-leukaemic activity - ecancer
ecancer,
A study published in the journalOncotargethas reported a preclinical study, which has characterised the binding affinity and…
A study published in the journalOncotargethas reported a preclinical study, which has characterised the binding affinity and…
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity…
.newsblock { width: 200px; height:200px; float:right; padding-left:15px; padding-right:15px; } Oncotarget Volume 11, Issue 11…
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity…